home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

1,493 rows where filing_period = "third_quarter", filing_year = 2019 and issue_code = "MMM" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

issue_code 1

  • MMM · 1,493 ✖

filing_year 1

  • 2019 · 1,493 ✖

filing_period 1

  • third_quarter · 1,493 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2336095 THE PETRIZZO GROUP, INC. 42ef3b00-9991-46e3-a11c-74950a586c74 3T THE PETRIZZO GROUP, INC. 305932 SEATTLE CANCER CARE ALLIANCE 2019 third_quarter MMM Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access. HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2019-08-23T12:04:42.920000-04:00
2336241 MR. THEODORE (TED) JONES 864e15d4-7725-40b5-95e4-f606bf1db4d7 3T MR. THEODORE (TED) JONES 20926 OCHSNER HEALTH SYSTEM, INC. 2019 third_quarter MMM Healthcare, Medicare and Medicaid HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2019-08-30T12:00:42.860000-04:00
2336999 RED MAPLE CONSULTING, LLC af335c88-2499-4dd7-becd-627265bcd197 3T RED MAPLE CONSULTING, LLC 400382761 POTOMAC PARTNERS DC (ON BEHALF OF ORANGE COUNTY, CA) 2019 third_quarter MMM Monitor regulations and legislation changing Medicare and Medicaid policies HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2019-09-17T09:34:50.763000-04:00
2337004 THE ROSS GROUP, LLC 81fe476e-e9e9-4fb0-994f-138a669bbaaa Q3 THE ROSS GROUP, LLC 400432094 THE HEALTHCARE LEADERSHIP COUNCIL 2019 third_quarter MMM provider payment HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2019-09-17T09:49:51.877000-04:00
2337005 THE ROSS GROUP, LLC 035647f0-f501-443a-99dd-3a3d4071e9c3 Q3 THE ROSS GROUP, LLC 400432094 ADVAULT, INC. 2019 third_quarter MMM Medicare Patient Empowerment Act Advance Care Planning Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-09-17T09:50:53.907000-04:00
2337161 HOSPICE COMPASSUS 8728bf25-9e8f-4622-872d-b8a4f095968c Q3 HOSPICE COMPASSUS 401103527 HOSPICE COMPASSUS 2019 third_quarter MMM Medicare hospice, palliative and Medicare Advantage PCHETA Rural Access to Hospice Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   60000 0 0 2019-09-20T13:17:31.337000-04:00
2337174 EASTERSEALS NEW JERSEY f61be9db-acd9-436c-94f1-627a32e5a974 3A EASTERSEALS NEW JERSEY 401105368 EASTEREALS NEW JERSEY 2019 third_quarter MMM Advocating against step therapy for Medicare Part B HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-09-20T15:43:45.403000-04:00
2337250 AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES 1e4f0f2a-b7dd-407e-acde-db775b0676c6 Q3 AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES 2957 AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES 2019 third_quarter MMM EVV, HCBS Settings Rule, HIPAA, ICF/IID Life Safety Code, MFP, 1115 waiver/block grant guidance Bureau of Labor Statistics (BLS),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Transportation, Dept of (DOT)   20000 0 0 2019-09-24T16:29:34.760000-04:00
2337448 MOSAIC 6e384baa-5916-43bb-94a0-4c6991d25a94 Q3 MOSAIC 6096 MOSAIC 2019 third_quarter MMM Advocacy on issues impacting people with disabilities including employment-related issues and Medicaid program changes. HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-09-30T12:16:29.913000-04:00
2337458 SOCIAL SECURITY WORKS 0b655fca-fb05-454b-8d5a-fcdd74aa0d45 Q3 SOCIAL SECURITY WORKS 401048957 SOCIAL SECURITY WORKS 2019 third_quarter MMM Medicare Negotiation and Competitive Licensing Act Medicare for All Act Stop the Wait Act Medigap Consumer Protection Act Medicare Dental, Vision and Hearing Benefit Act HOUSE OF REPRESENTATIVES,SENATE,Social Security Administration (SSA)   12000 0 0 2019-09-30T13:06:35.800000-04:00
2337647 SHUMAKER ADVISORS FLORIDA, LLC 09b9811d-5b90-4775-a620-483d8803a701 Q3 SHUMAKER ADVISORS FLORIDA, LLC 401104468 GRACEPOINT WELLNESS 2019 third_quarter MMM In-patient Medicare coverage for mental health HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-01T13:14:36.853000-04:00
2337766 MCDERMOTT WILL & SCHULTE LLP ab867e9c-f2a2-41cd-8feb-83cf42913912 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ABIOMED, INC. 2019 third_quarter MMM Issues related to Medicare reimbursement and the medical device tax. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-01T15:16:24.517000-04:00
2337850 MJWT CONSULTING 36440a47-703d-46a9-9341-2db3755fbb82 Q3 MJWT CONSULTING 69696 WELLMED MEDICAL MANAGEMENT INC 2019 third_quarter MMM Medicare/Medicare Advantage legislative issues HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-02T07:31:29.427000-04:00
2337915 AMERICAN COLLEGE OF CLINICAL PHARMACY 9297e66e-eb69-45df-a2c1-d3c66673a028 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2019 third_quarter MMM Promote enhanced quality, structure and information dissemination concerning medication therapy management services (MTMS) under Medicare Part D. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   144981 0 0 2019-10-02T10:28:01.477000-04:00
2338011 JOHNSTON GROUP, LLC b9afd040-e700-4155-be00-2dbe50cc619b Q3 JOHNSTON GROUP, LLC 400383768 ASTRIA HEALTH (FORMERLY KNOWN AS SUNNYSIDE COMMUNITY HOSPITAL) 2019 third_quarter MMM Impact of sequestration on Medicare reimbursement rates. Support for Critical Access Hospital reimbursement rates without changes. Support for new CMS program that would allow a Critical Access Hospital to transition to a traditional CMS payment model over a ten year period. Impact of Section 603 of the Budget Act of 2015 on hospital reimbursement. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-02T13:53:58.437000-04:00
2338017 JOHNSTON GROUP, LLC 886b5953-5acb-43a2-af72-7e18397038fb Q3 JOHNSTON GROUP, LLC 400383768 ISLAND HOSPITAL 2019 third_quarter MMM Impact of sequestration on Medicare reimbursement rates. Graduate Medical Education (GME) program establishment. Support for GME incentives to train primary care physicians Impact of GME and Direct Medical Education (DME) reimbursement cuts. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-10-02T13:55:00.420000-04:00
2338055 AMERICAN CAPITOL GROUP 2aa6edfc-b9b3-4653-9bfe-83d424317167 Q3 AMERICAN CAPITOL GROUP 305852 IPSEN BIOPHARMACEUTICALS, INC. 2019 third_quarter MMM Medicare Part D issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-02T15:38:24.240000-04:00
2338057 AMERICAN CAPITOL GROUP 8bfd9800-9c0f-4dce-8fa0-42a4e6532f68 Q3 AMERICAN CAPITOL GROUP 305852 HEARTFLOW 2019 third_quarter MMM Medicare Reimbursement Issues Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-10-02T15:39:24.927000-04:00
2338099 CHRISTOPHER MOYER 8b473954-1098-4bd3-92b5-798c021b5747 Q3 CHRISTOPHER MOYER 401093053 CAMERON COMPANIES 2019 third_quarter MMM Monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies, such as CAR-T. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-10-03T09:02:04.737000-04:00
2338101 CAMERON COMPANIES cfb8697f-6e73-4a24-88ef-a0307bb5c136 Q3 CAMERON COMPANIES 401095057 FOX CHASE CANCER CENTER 2019 third_quarter MMM Monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies and site neutrality. Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-03T09:06:06.240000-04:00
2338118 MARSHALL BRACHMAN b9a597dd-10f3-4a3b-84f9-07754377518b Q3 MARSHALL BRACHMAN 6848 BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM 2019 third_quarter MMM monitor post acute care and other site neutral medicare cuts; support legislation for relief of existing physician owned hospitals;monitor legislation affecting hospital not-for-profit status;monitor 340B program;monitor UNOS/HRSA liver transplant protocols HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2019-10-03T09:25:10.797000-04:00
2338136 MARSHALL BRACHMAN 5c0ffeba-6dc7-4ed6-88e5-b9e96054c377 Q3 MARSHALL BRACHMAN 6848 OKLAHOMA HEART HOSPITAL 2019 third_quarter MMM support legislation to allow for growth of hospitals with physician ownership HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-10-03T09:37:16.843000-04:00
2338139 MARSHALL BRACHMAN 228f010f-f834-48fe-8dab-2a86bcf2374b Q3 MARSHALL BRACHMAN 6848 CARDIOLOGY ADVOCACY ALLIANCE 2019 third_quarter MMM oppose cuts to advanced medical imaging;support appropriateness criteria for diagnostic imaging;oppose site neutral cuts;monitor legislation affecting EHR and HIT HOUSE OF REPRESENTATIVES,SENATE 33000   0 0 2019-10-03T09:43:19.023000-04:00
2338156 WAKE FOREST UNIVERSITY HEALTH SCIENCES cf6271fe-e19f-4ad1-bf1d-2ec376aacdeb Q3 WAKE FOREST UNIVERSITY HEALTH SCIENCES 6781 WAKE FOREST UNIVERSITY HEALTH SCIENCES 2019 third_quarter MMM Continuing Resolution (Medicare & Medicaid Extenders); Community Health Investment Modernization And Excellence Act of 2019,(H.R. 2328) provisions including Medicaid Disproportionate Share (DSH) payments, the reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and workforce programs; and "Lower Healthcare Costs Act, (S. 1895) regarding surprise billing, drug pricing and price transparency; 340B Drug Pricing Program; Resident Physicians Shortage Reduction Act of 2019. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2019-10-03T11:07:30.787000-04:00
2338161 NORTH CAROLINA BAPTIST HOSPITAL 1a14890f-ee0a-431f-bc45-b8dd37ed133c Q3 NORTH CAROLINA BAPTIST HOSPITAL 46723 NORTH CAROLINA BAPTIST HOSPITAL 2019 third_quarter MMM Continuing Resolution (Medicare & Medicaid Extenders); Community Health Investment Modernization And Excellence Act of 2019,(H.R. 2328) provisions including Medicaid Disproportionate Share (DSH) payments, the reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and workforce programs; and "Lower Healthcare Costs Act, (S. 1895) regarding surprise billing, drug pricing and price transparency; 340B Drug Pricing Program; Resident Physicians Shortage Reduction Act of 2019. HOUSE OF REPRESENTATIVES,SENATE   25000 0 0 2019-10-03T11:13:32.527000-04:00
2338222 MERCURY PUBLIC AFFAIRS, LLC 351dd387-ee52-422f-9fca-3299fd904852 Q3 MERCURY PUBLIC AFFAIRS, LLC 70175 AMERISOURCE BERGEN 2019 third_quarter MMM General healthcare related to pharmaceuticals distribution Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2019-10-03T13:19:57.063000-04:00
2338252 MWR CONSULTING 47b81b19-d17e-4944-b49d-a212d43d79f7 Q3 MWR CONSULTING 401104301 UNITEDHEALTH GROUP 2019 third_quarter MMM Medicare Advantage HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2019-10-03T13:52:14.667000-04:00
2338253 MERCURY PUBLIC AFFAIRS, LLC dc0cd8bf-cf46-413d-b0e3-119a0bd120ae Q3 MERCURY PUBLIC AFFAIRS, LLC 70175 BLUE CROSS BLUE SHIELD OF SOUTH CAROLINA 2019 third_quarter MMM General Healthcare and Medicare (CMS) program contracts Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 40000   0 0 2019-10-03T13:53:15.340000-04:00
2338259 MWR CONSULTING 99a782f1-b6c4-4236-a857-ef41b5aa2ae0 Q3 MWR CONSULTING 401104301 HOLLISTER, INC. 2019 third_quarter MMM Reimbursement for medical devices under Medicare & Medicaid Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 25000   0 0 2019-10-03T13:59:18.503000-04:00
2338267 MWR CONSULTING 0b128acc-d6bb-4302-ab89-a737ef0e23de Q3 MWR CONSULTING 401104301 PENN HILL GROUP ON BEHALF OF HOLLISTER, INC. 2019 third_quarter MMM Reimbursements for medical products under Medicare/Medicaid Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-10-03T14:07:22.780000-04:00
2338419 MILLER & WENHOLD CAPITOL STRATEGIES 33b08152-ff24-4b5c-9dae-69c263ff91d9 Q3 MILLER & WENHOLD CAPITOL STRATEGIES 307034 THE TRANSPORTATION ALLIANCE (FORMERLY TAXICAB, LIMOUSINE & PARATRANSIT ASSN.) 2019 third_quarter MMM Non-emergency Medical Transportation benefits - proposed cuts. Centers For Medicare and Medicaid Services (CMS),General Services Administration (GSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-04T09:28:15.793000-04:00
2338510 POWER TO DECIDE 75d67997-8711-4fc4-94ed-136cd690e281 Q3 POWER TO DECIDE 400275303 POWER TO DECIDE 2019 third_quarter MMM Medicaid coverage of family planning HOUSE OF REPRESENTATIVES,SENATE   69194 0 0 2019-10-04T11:32:28.053000-04:00
2338676 NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE 382e271e-39ef-4166-b5f1-2567f74c9a8e Q3 NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE 27467 NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE 2019 third_quarter MMM Drug Pricing. H.R. 3, the Lower Drug Costs Now Act: Proposals to authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices on behalf of Medicare with pharmaceutical manufactureres. Create a maximum price for any negotiated drug with an international price index (Average International Market price). Require drug manufacturers that refuse to negotiation with HHS to pay a Non-Compliance Fee of 65 percent of the gross sales of the drug in question. Require drug companies that raised the price of a drug in Medicare above the rate of inflation since 2016 to either lower the price or pay the entire price above inflation in a rebate back to the Treasury. Create a $2,000 Medicare beneficiary annual out-of-pocket cost cap for prescription drugs. Drug Pricing. S. 2543, the Prescription Drug Pricing Reduction Act of 2019: Require pharmaceutical manufacturers to rebate Medicare if they raise their prices for drugs covered by Medicare Parts B and D faster than inflation. Establish an out-of-pocket spending limit in which Medicare beneficiaries would pay no more than $3,100 a year on drug costs. Require Medicare Part D private insurers to pay 60 percent and, drug makers 20 percent, of the costs incurred over the out-of-pocket spending cap. Increase transparency into pharmacy benefit manager practices and manufacturer drug pricing decisions. Provide state Medicaid programs with more authority to contain drug prices. Drug Pricing. H.R. 1046, the Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health and Human Services to directly negotiate prices for prescription drugs and issue a competitive license allowing other manufacturers to produce the drug for Medicare in the event negotiations fail. Drug Pricing. S. 1895, the Lower Health Care Costs Act of 2019: Proposals to reduce the cost of prescription drugs including allowing generic drug manufacturers to sue brand-name manufacturers for not selling them samples for testing necessary to get to market; and re… Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,Social Security Administration (SSA),Treasury, Dept of   190000 0 0 2019-10-04T13:44:22.567000-04:00
2338711 LANTHEUS HOLDINGS, INC. db6f037e-4602-4412-b386-01bb50e8044b Q3 LANTHEUS HOLDINGS, INC. 401105198 LANTHEUS HOLDINGS, INC. 2019 third_quarter MMM H.R. 3772 Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2019-10-04T14:16:33.327000-04:00
2338783 MR. MICHAEL ROMANSKY 4607fdea-9df5-4c1f-915b-1ec8fc975a6c Q3 MR. MICHAEL ROMANSKY 400418985 OUTPATIENT OPHTHALMIC SURGERY SOCIETY, INC 2019 third_quarter MMM Lobbying for HR 1453 and S 2071, "The ASC Quality and Access Act of 2015", for reasonable payment and quality reporting rules for ambulatory surgical centers. Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE 50000   0 0 2019-10-04T17:08:15.683000-04:00
2338800 MISSION GOVERNMENT RELATIONS (FORMERLY KNOWN AS MUROFF LAW FIRM, LLC) 9094fac4-06c3-44e5-ad0d-636c6c5f166b Q3 MISSION GOVERNMENT RELATIONS (FORMERLY KNOWN AS MUROFF LAW FIRM, LLC) 314033 JEVS HUMAN SERVICES 2019 third_quarter MMM Medicaid and associated healthcare funding workforce development and training HOUSE OF REPRESENTATIVES,SENATE 10500   0 0 2019-10-05T10:22:38.607000-04:00
2338884 NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE 471b28a9-b610-4315-a773-331d61786141 3A NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE 27467 NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE 2019 third_quarter MMM Drug Pricing. H.R. 3, the Lower Drug Costs Now Act: Proposals to authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices on behalf of Medicare with pharmaceutical manufactureres. Create a maximum price for any negotiated drug with an international price index (Average International Market price). Require drug manufacturers that refuse to negotiation with HHS to pay a Non-Compliance Fee of 65 percent of the gross sales of the drug in question. Require drug companies that raised the price of a drug in Medicare above the rate of inflation since 2016 to either lower the price or pay the entire price above inflation in a rebate back to the Treasury. Create a $2,000 Medicare beneficiary annual out-of-pocket cost cap for prescription drugs. Drug Pricing. S. 2543, the Prescription Drug Pricing Reduction Act of 2019: Require pharmaceutical manufacturers to rebate Medicare if they raise their prices for drugs covered by Medicare Parts B and D faster than inflation. Establish an out-of-pocket spending limit in which Medicare beneficiaries would pay no more than $3,100 a year on drug costs. Require Medicare Part D private insurers to pay 60 percent and, drug makers 20 percent, of the costs incurred over the out-of-pocket spending cap. Increase transparency into pharmacy benefit manager practices and manufacturer drug pricing decisions. Provide state Medicaid programs with more authority to contain drug prices. Drug Pricing. H.R. 1046, the Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health and Human Services to directly negotiate prices for prescription drugs and issue a competitive license allowing other manufacturers to produce the drug for Medicare in the event negotiations fail. Drug Pricing. S. 1895, the Lower Health Care Costs Act of 2019: Proposals to reduce the cost of prescription drugs including allowing generic drug manufacturers to sue brand-name manufacturers for not selling them samples for testing necessary to get to market; and re… Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,Social Security Administration (SSA),Treasury, Dept of   190000 0 0 2019-10-07T10:29:25.720000-04:00
2338963 CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC 01c879a2-c603-4c09-b730-57a9ed0e4b57 Q3 CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC 401104914 AMERICAN COLLEGE OF CLINICAL PHARMACY 2019 third_quarter MMM coverage and recognition for comprehensive medication management Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-07T12:45:27.543000-04:00
2338972 GENESIS HEALTHCARE INC (FORMERLY LISTED AS GENESIS HEALTHCARE CORPORATION) 2503b141-2eb8-4704-8b92-4f71af20688e Q3 GENESIS HEALTHCARE INC (FORMERLY LISTED AS GENESIS HEALTHCARE CORPORATION) 40049384 GENESIS HEALTHCARE INC (FORMERLY LISTED AS GENESIS HEALTHCARE CORPORATION) 2019 third_quarter MMM 16. Specific lobbying issues (i) CMS FY20 SNF PPS final rules and notice of proposed changes in SNF case-mix and payment methodology for FY20;(ii) CMS implementation of quality measures/IMPACT Act provisions; and (iii) CMS proposed revisions in requirements of Long Term Care Facilities Requirements listed in Unified Agenda of Regulatory and Deregulatory Actions. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   20000 0 0 2019-10-07T13:19:32.103000-04:00
2339057 MCDERMOTT+ LLC 2c970a67-e0e2-4409-9fa5-76302ca16192 Q3 MCDERMOTT+ LLC 401103287 340B HEALTH 2019 third_quarter MMM Issues relating to the 340B drug pricing program. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-07T14:59:23.293000-04:00
2339110 AMERICAN ASSOCIATION OF CHILD & ADOLESCENT PSYCHIATRY 81d2b102-aa14-4f52-9e0d-de2dfa8e875d Q3 AMERICAN ASSOCIATION OF CHILD & ADOLESCENT PSYCHIATRY 401103274 AMERICAN ASSOCIATION OF CHILD & ADOLESCENT PSYCHIATRY 2019 third_quarter MMM Medicaid reform and expansion support H.R.1920 Medicaid Bump Act Funding for Children's Hospital Graduate Medical Education (CHGME) Executive Office of the President (EOP),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office   40000 0 0 2019-10-07T16:54:22.517000-04:00
2339127 CAPITOL IMPACT, LLC bb6bccb6-da8c-4498-896c-58fa172a212f Q3 CAPITOL IMPACT, LLC 284471 THE LIVINGSTON GROUP, LLC (RUSH UNIVERSITY MEDICAL CENTER) 2019 third_quarter MMM H.R. 1533/S. 782 - Improving Access to Mental Health Act Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-07T20:31:06.843000-04:00
2339164 RETIRESAFE a3e9b959-a4bc-4e4c-a891-8faa1524a783 Q3 RETIRESAFE 11025 RETIRESAFE 2019 third_quarter MMM Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   38750 0 0 2019-10-08T09:08:29.523000-04:00
2339172 MCDERMOTT+ LLC 92c4dffd-46a0-4404-ad4f-8f6211460e1b Q3 MCDERMOTT+ LLC 401103287 AMERICA'S ESSENTIAL HOSPITALS 2019 third_quarter MMM General issues relating to Medicare, Medicaid, disproportionate share hospital payment, and 340B. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-08T09:37:43.120000-04:00
2339176 MCDERMOTT+ LLC 380d9bd0-6f9c-4321-9b4c-f6a0004ad9df Q3 MCDERMOTT+ LLC 401103287 ASSOCIATION FOR COMMUNITY AFFILIATED PLANS 2019 third_quarter MMM Issues relating to Medicaid, Medicare, and the Marketplace, short-term limited duration insurance plans, and association health plans. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-08T09:57:36.287000-04:00
2339179 ELEKTA, INC. 92d5305f-ec5b-48ea-8636-785bed3969c9 Q3 ELEKTA, INC. 401103218 ELEKTA, INC. 2019 third_quarter MMM Issues related to oncology treatment products and services Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   130000 0 0 2019-10-08T09:57:37.067000-04:00
2339192 DEXCOM, INC. 4c8a81e4-89fa-4815-a9e9-98d42b5eb569 Q3 DEXCOM, INC. 401104564 DEXCOM, INC. 2019 third_quarter MMM CMS Coverage Policies and Reimbursement Centers For Medicare and Medicaid Services (CMS)   56274 0 0 2019-10-08T10:17:12.390000-04:00
2339223 REPUBLIC CONSULTING, LLC dd4b7c8a-fc3b-43f1-a6dd-0ee16c5ea32e Q3 REPUBLIC CONSULTING, LLC 401016871 PERSONAL CONNECTED HEALTH ALLIANCE 2019 third_quarter MMM Monitor Connected Health Policy. Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-08T10:50:05.853000-04:00
2339228 REPUBLIC CONSULTING, LLC 53666e5d-5adb-44d5-8f29-d46832b7f257 Q3 REPUBLIC CONSULTING, LLC 401016871 WW INTERNATIONAL (FORMERLY KNOWN AS WEIGHT WATCHERS) 2019 third_quarter MMM Monitor wellness and obesity treatment policy. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-08T10:53:08.547000-04:00
2339234 POLSINELLI PC 63e3bd82-3616-4a42-be7b-85955b787308 Q3 POLSINELLI PC 314911 HEARING INDUSTRIES ASSOCIATION 2019 third_quarter MMM Issues pertaining to the coverage of hearing aid devices. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-08T11:04:56.020000-04:00
2339254 POLSINELLI PC 0bf10731-ecfe-41cf-94fd-cb2dae039f20 Q3 POLSINELLI PC 314911 TRIDENTUSA HEALTH SERVICES 2019 third_quarter MMM Issues related to bundled payments for clinical laboratory services provided to nursing homes and home bound patients. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-08T11:20:49.420000-04:00
2339273 MCDERMOTT+ LLC e9e318e8-6b90-4bb4-9109-86e75816758f 3T MCDERMOTT+ LLC 401103287 CHRISTIAN FAMILY MEDICINE 2019 third_quarter MMM Issues relating to a Medicaid State Plan Amendment. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE     0 1 2019-10-08T11:33:57.567000-04:00
2339282 MCDERMOTT+ LLC 474ce21f-e223-4326-a3fc-af62c4ffd58a Q3 MCDERMOTT+ LLC 401103287 CVS HEALTH 2019 third_quarter MMM General issues relating to PBMs. Issues relating to prescription drug pricing, including H.R. 3 Lower Drug Costs Now Act of 2019, S. 1895 Lower Health Care Costs Act, and S. 2543 The Prescription Drug Pricing Reduction Act of 2019. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2019-10-08T11:58:17.517000-04:00
2339326 NATIONAL ASSOCIATION OF POSTAL SUPERVISORS e4f03ba2-6a4c-487f-9c06-11eac55b2967 Q3 NATIONAL ASSOCIATION OF POSTAL SUPERVISORS 401075023 NATIONAL ASSOCIATION OF POSTAL SUPERVISORS 2019 third_quarter MMM Legislation that could impact the coordination between FEHBP and Medicare HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),Postal Regulatory Commission,SENATE,Treasury, Dept of,U.S. Postal Service (USPS)   15000 0 0 2019-10-08T12:58:08.377000-04:00
2339350 MEDICAL DEVICE MANUFACTURERS ASSOCIATION 7bf20517-40c5-4eb9-a7a6-34dfb84a17c1 Q3 MEDICAL DEVICE MANUFACTURERS ASSOCIATION 24794 MEDICAL DEVICE MANUFACTURERS ASSOCIATION 2019 third_quarter MMM Issues relating to Reimbursement of Medical Devices Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE   300000 0 0 2019-10-08T13:36:09.673000-04:00
2339352 MICHAEL N. MCCARTY LAW OFFICE PLLC 096e58a0-eabb-4772-bbf3-fc6f822c65ad Q3 MICHAEL N. MCCARTY LAW OFFICE PLLC 401104300 AMERICAN MEDICAL TECHNOLOGISTS 2019 third_quarter MMM Support proposed amendments to Section 216 of the Protecting Access to Medicare Act of 2014, including H.R. 3584 (Laboratory Access for Beneficiaries Act); legislation affecting payments under the Medicare Clinical Laboratory Fee Schedule. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-10-08T13:40:11.257000-04:00
2339418 BAYADA HEARTS FOR HOMECARE e6fbc4db-73d6-4d1e-90c5-59d79188652b Q3 BAYADA HEARTS FOR HOMECARE 401105103 BAYADA HEARTS FOR HOMECARE 2019 third_quarter MMM H.R. 2573/S.433 Home Health Payment Innovation Act of 2019; HOUSE OF REPRESENTATIVES,SENATE   11000 0 0 2019-10-08T14:57:21.510000-04:00
2339429 FAEGRE DRINKER BIDDLE & REATH LLP c99d5635-6491-4c14-abb4-b88402f18c80 3T FAEGRE DRINKER BIDDLE & REATH LLP 12631 INTEGRA LIFESCIENCES 2019 third_quarter MMM Medicare reimbursement on wound care. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2019-10-08T15:27:35.753000-04:00
2339495 AMERICAN AMBULANCE ASSOCIATION 4074cd4a-ea1a-4b59-b3c4-fa8fb6ce9fed Q3 AMERICAN AMBULANCE ASSOCIATION 56018 AMERICAN AMBULANCE ASSOCIATION 2019 third_quarter MMM Lobbied on increases to rates under the Medicare ambulance fee schedule and improvements on Medicare and Medicaid policies on ambulance services including CMMI pilot programs and a cost data collection system. Lobbied on the draft Medicare Ambulance Access, Fraud Prevention and Reform Act and the Non-Emergency Ambulance Transportation Sustainability and Accountability (NEATSA) Act of 2019 (S. 228, H.R. 3201). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   180000 0 0 2019-10-09T08:29:26.800000-04:00
2339557 COLLEGE OF HEALTHCARE INFORMATION MANAGEMENT EXECUTIVES 06a24f78-8fcb-41e7-90bc-ff48657501ff Q3 COLLEGE OF HEALTHCARE INFORMATION MANAGEMENT EXECUTIVES 401103450 COLLEGE OF HEALTHCARE INFORMATION MANAGEMENT EXECUTIVES 2019 third_quarter MMM Medicare and Medicaid EHR Incentive Program, Medicare Access and CHIP Reauthorization Act, Telehealth and Remote Patient Monitoring, patient matching/identification, Cybersecurity, HIPAA Privacy, Conditions of Participation, Interoperability, Lower Health Care Costs (S.1895,) Repeal National Patient ID Act (S. 2538) Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office   25000 0 0 2019-10-09T09:48:50.477000-04:00
2339564 MCDERMOTT+ LLC fc2d7aab-3d3c-447e-8450-ac37a55bfdc2 Q3 MCDERMOTT+ LLC 401103287 LYMPHEDEMA ADVOCACY GROUP 2019 third_quarter MMM Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948). HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-09T10:31:09.907000-04:00
2339586 MCDERMOTT+ LLC ec2221c8-b07c-4067-b538-a42c2812b3c0 Q3 MCDERMOTT+ LLC 401103287 NATIONAL ASSOCIATION OF COUNTIES 2019 third_quarter MMM General issues relating to Medicare and Medicaid. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-09T11:03:01.807000-04:00
2339598 THE CJR GROUP, INC. 11d7a67b-0cd9-4a97-9959-ca7a8e1de465 Q3 THE CJR GROUP, INC. 288293 BELLEFAIRE JCB 2019 third_quarter MMM FQHC HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-10-09T11:32:51.500000-04:00
2339599 DOCTORS HOSPITAL AT RENAISSANCE 9dce48aa-51b9-443e-8cd9-638d09d46fd6 Q3 DOCTORS HOSPITAL AT RENAISSANCE 400479360 DOCTORS HOSPITAL AT RENAISSANCE 2019 third_quarter MMM Medicare and Medicaid policy, DSH funding, physician owned hospital restrictions, Stark law, Medicaid and Medicaid regulations, health care issues, Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   80000 0 0 2019-10-09T11:32:52.530000-04:00
2339614 THE CJR GROUP, INC. b65012d4-2dfe-42f8-a17a-fd23e02cad7f Q3 THE CJR GROUP, INC. 288293 UNIVERSITY HOSPITALS HEALTH SYSTEM 2019 third_quarter MMM CMS rules HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-09T11:35:00.047000-04:00
2339628 INTEREL US 4cdbe567-0a59-4661-8cd1-e8b23c2a1484 Q3 INTEREL US 401104823 AMERICAN AMBULANCE ASSOCIATION 2019 third_quarter MMM Lobbied on increases to rates under the Medicare ambulance fee schedule and improvements on Medicare and Medicaid policies on ambulance services including CMMI pilot programs and a cost data collection system. Lobbied on the draft Medicare Ambulance Access, Fraud Prevention and Reform Act and the Non-Emergency Ambulance Transportation Sustainability and Accountability (NEATSA) Act of 2019 (S. 228, H.R. 3021). Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA) 70000   0 0 2019-10-09T11:40:10.307000-04:00
2339641 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 6ea7de68-8965-4213-b128-e53e4ccf37d1 Q3 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 1466 ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) 2019 third_quarter MMM On July 10, 2019 AACC wrote to Rep. Scott Peters endorsing H.R.3584, the Laboratory Access for Beneficiaries Act, which seeks to ensure that the payment amounts on the new market-based clinical laboratory fee schedule, authorized under the Protecting Access to Medicare Act (PAMA), are accurate. On August 20, 2019 ACC wrote to Rep. Judy Chu endorsing H.R.3031, which would reauthorize the National Quality Forum (NQF) through 2024 at $30 million annually. HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2019-10-09T12:01:02.487000-04:00
2339653 AMERICAN AMBULANCE ASSOCIATION ff5d0860-f2d7-4cae-8c60-f6216b5856b1 3A AMERICAN AMBULANCE ASSOCIATION 56018 AMERICAN AMBULANCE ASSOCIATION 2019 third_quarter MMM Lobbied on increases to rates under the Medicare ambulance fee schedule and improvements on Medicare and Medicaid policies on ambulance services including CMMI pilot programs and a cost data collection system. Lobbied on the draft Medicare Ambulance Access, Fraud Prevention and Reform Act and the Non-Emergency Ambulance Transportation Sustainability and Accountability (NEATSA) Act of 2019 (S. 228, H.R. 3201). Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)   180000 0 0 2019-10-09T12:02:25.613000-04:00
2339819 ACG ADVOCACY 8572f97c-2720-420d-bff6-14f8145f0c56 Q3 ACG ADVOCACY 2057 CAPITAL DISTRICT PHYSICIAN'S HEALTH PLAN INC 2019 third_quarter MMM Medicare Advantage Issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-09T15:05:58.190000-04:00
2339890 COREWELL HEALTH 66d48239-5be8-4b2c-baee-980ff07ef18f Q3 COREWELL HEALTH 298455 COREWELL HEALTH 2019 third_quarter MMM H.R.1839 - Medicaid Services Investment and Accountability Act of 2019. ACE Kids Act discussions. S. 773 - Telehealth Innovation and Improvement Act of 2019. Discussions regarding proposal. Presidents Executive Order on health care transparency. Discussions related to proposals to increase heath care transparency. Discussions around proposed changes to the Medicare Advantage benchmark cap. H.R. 3107 - Improving Seniors' Time Access to Care Act of 2019. Discussions around Prior Authorization legislation. Discussions around "site-neutral" cuts and Medicaid Disproportionate Share Hospital Program cuts. HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2019-10-09T16:03:11.807000-04:00
2339896 FAEGRE DRINKER BIDDLE & REATH LLP 632cfe3f-85c7-435a-add5-5a2312db6b0a 3T FAEGRE DRINKER BIDDLE & REATH LLP 12631 NATIONAL ASSOCIATION OF SPECIALTY PHARMACY 2019 third_quarter MMM Medicare Direct and Indirect Remuneration. H.R. 1034, S. 640 Phair Pricing Act of 2019. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 40000   0 1 2019-10-09T16:19:37.720000-04:00
2340005 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b75c7a80-94b9-4382-b662-1049dae05fe8 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN ASSN FOR THE STUDY OF LIVER DISEASES 2019 third_quarter MMM Medicare reimbursement rates MACRA Implementation Chronic Care Reform Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2019-10-10T16:04:42.020000-04:00
2340020 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9cb35452-a4ca-4466-9e2b-bfeba395d41b Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 SOCIETY OF GENERAL INTERNAL MEDICINE 2019 third_quarter MMM P.L. 111-148/P.L. 111-152, Affordable Care Act, physician reimbursement issues P.L. 114-10, Medicare Access and CHIP reauthorization Act implementation Chronic Care Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2019-10-10T16:04:50.427000-04:00
2340033 AMERICAN CHIROPRACTIC ASSOCIATION ca91ed66-668f-44cf-a9de-689aabd534f2 Q3 AMERICAN CHIROPRACTIC ASSOCIATION 1898 AMERICAN CHIROPRACTIC ASSOCIATION 2019 third_quarter MMM HR 1384: Medicare for All Act; ensure chiropractic access HR 1346: Medicare at 50 Act; ensure chiropractic access S. 470: Medicare at 50 Act; ensure chiropractic access HR 3654:Chiropractic Medicare Coverage Modernization Act; providing access to all Medicare-covered services allowed under a chiropractor's licensure HOUSE OF REPRESENTATIVES,SENATE   71750 0 0 2019-10-10T16:04:56.520000-04:00
2340127 HORIZON GOVERNMENT AFFAIRS 2638d3ef-3d48-4e28-b4c7-12feb348d75d Q3 HORIZON GOVERNMENT AFFAIRS 315592 NATIONAL KIDNEY FOUNDATION 2019 third_quarter MMM Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-10-10T16:05:42.287000-04:00
2340182 CORPORATION FOR SUPPORTIVE HOUSING 8f0b2879-0c7c-4cc8-8004-44a76f80020d Q3 CORPORATION FOR SUPPORTIVE HOUSING 69195 CORPORATION FOR SUPPORTIVE HOUSING 2019 third_quarter MMM Medicaid Waivers 1115 and 1915i Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,Treasury, Dept of   50000 0 0 2019-10-10T16:06:20.490000-04:00
2340187 CAPITOL HILL STRATEGIES, LLC 48b3c17c-ffc7-47d6-a37f-92e66f7ffacc Q3 CAPITOL HILL STRATEGIES, LLC 91774 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2019 third_quarter MMM Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals. Issues relating to biologics and biosimilars in Medicare and generally. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-10-10T16:06:21.397000-04:00
2340256 WEST FRONT STRATEGIES LLC 562515bf-c1bd-4019-9c1e-1896a9228505 Q3 WEST FRONT STRATEGIES LLC 401103493 AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.) 2019 third_quarter MMM Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologist as physicians, for purposes of providing clinical psychologist services under Medicare, including H.R. 884. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-10T16:36:58.687000-04:00
2340436 HEALTHCARE LEADERSHIP COUNCIL 056316e6-674e-4f5c-a201-cdcae5d2e689 Q3 HEALTHCARE LEADERSHIP COUNCIL 17933 HEALTHCARE LEADERSHIP COUNCIL 2019 third_quarter MMM H.R. 1530 Treat and Reduce Obesity Act S. 595 Treat and Reduce Obesity Act H.R. 1763 Resident Physician Shortage Reduction Act S. 348 Resident Physician Shortage Reduction Act H.R. 2062 Overdose Prevention and Patient Safety Act H.R. 2207 Protect Medical Innovation Act S. 692 Protect Medical Innovation Act H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 H.R. 3461 - Community-Based Independence for Seniors Act of 2019 H.R. 3796 - Health Savings for Seniors Act H.R. 4013 Telehealth Innovation and Improvement Act S. 773 - Telehealth Innovation and Improvement Act S. 1012 Protecting Jessica Grubbs Legacy Act S. 1323 - Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health (UNDERSTAND) Act S. 1842 - Protecting Personal Health Data Act S. 1895 Lower Health Care Costs Act Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   180000 0 0 2019-10-11T09:48:55.763000-04:00
2340484 OSF HEALTHCARE SYSTEM a7702aca-5326-4be8-8526-bd322c5f76b6 Q3 OSF HEALTHCARE SYSTEM 56394 OSF HEALTHCARE SYSTEM 2019 third_quarter MMM Advocated for maintaining existing or increase in funding levels as it relates to medicaid and medicare. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   60000 0 0 2019-10-11T10:45:20.837000-04:00
2340588 THE CACTUS GROUP, LLC f8c0b323-b2fb-4348-90b5-cd549d040bae Q3 THE CACTUS GROUP, LLC 401105143 MERCK & CO. 2019 third_quarter MMM HR 5712 - Medicaid Drug Rebate Accountability Act - bill in its entirety (oppose) HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2019-10-11T11:53:32.483000-04:00
2340591 BEN BARNES GROUP LP e1412ba6-1f6f-4c0d-b701-c0d76d7b823f Q3 BEN BARNES GROUP LP 5415 HUNTSMAN CANCER INSTITUTE 2019 third_quarter MMM Medicare Prospective Payment System Exemption HOUSE OF REPRESENTATIVES,SENATE     0 0 2019-10-11T11:54:34.360000-04:00
2340674 SENTRY INSURANCE COMPANY (FORMERLY SENTRY INSURANCE A MUTUAL COMPANY) b39e6d60-b32e-4bc0-a20e-7fa6a75f2c1e Q3 SENTRY INSURANCE COMPANY (FORMERLY SENTRY INSURANCE A MUTUAL COMPANY) 401104022 SENTRY INSURANCE COMPANY (FORMERLY SENTRY INSURANCE A MUTUAL COMPANY) 2019 third_quarter MMM HR 1575 PAID Act, all provisions - We support this bill HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2019-10-11T13:55:18.903000-04:00
2340683 SQUIRE PATTON BOGGS 5ee01b3b-b901-4d00-ad1d-fea84515cd23 Q3 SQUIRE PATTON BOGGS 30906 COLORADO COALITION FOR DEVELOPMENTAL DISABILITIES 2019 third_quarter MMM As leader of a coalition of Colorado Community Centered boards, Developmental Pathways is seeking to extend the compliance timeline and clarify provisions of CMS HCBS rules on conflict-free case management. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-11T14:02:24.240000-04:00
2340729 NATIONAL KIDNEY FOUNDATION 76a93f52-083a-4179-b67b-2b1800632c31 Q3 NATIONAL KIDNEY FOUNDATION 28105 NATIONAL KIDNEY FOUNDATION 2019 third_quarter MMM Early detection and management of Chronic Kidney Disease, including Alternative Payment Model Increased utilization of home dialysis Extension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased use of Kidney Discards for transplantation Access of medications under Medicare Part D Protected Classes Comments on proposed rule on ESRD Treatment Choices Model Comments on ESRD Prospective Payment System and Quality Incentive Program Comments on interpretive guidance Conditions of Participation for organ transplant programs Comments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   100000 0 0 2019-10-11T14:22:49.063000-04:00
2340743 MCDERMOTT+ LLC 54c6cef0-6f8b-4a7e-844a-c837c482fe14 Q3 MCDERMOTT+ LLC 401103287 CAMPAIGN FOR SUSTAINABLE DRUG PRICING 2019 third_quarter MMM Issues relating to prescription drug pricing HHS Rebate Rule Medicare Part D benefit re-design H.R. 2113 - Prescription Drug STAR Act S. 551 - Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act H.R. 3 - Lower Drug Costs Now Act of 2019 S. 2543 - Prescription Drug Pricing Reduction Act of 2019 Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2019-10-11T14:31:55.327000-04:00
2340788 IPOLICY SOLUTIONS d8e95bee-2184-4f6b-bb45-9a320da70cfe Q3 IPOLICY SOLUTIONS 401105127 ASSOCIATION FOR MOLECULAR PATHOLOGY 2019 third_quarter MMM Medicare coverage of next generation sequencing based tests for cancer HR4393, Advancing Access to Precision Medicine Act Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2019-10-11T15:05:28.917000-04:00
2340795 IPOLICY SOLUTIONS 731c97b8-97d4-410d-be26-af20a7fd9401 Q3 IPOLICY SOLUTIONS 401105127 INVITAE INC. 2019 third_quarter MMM Medicare coverage of next generation sequencing based tests for cancer H.R.4393 - Advancing Access to Precision Medicine Act HOUSE OF REPRESENTATIVES,SENATE 58000   0 0 2019-10-11T15:12:33.817000-04:00
2340897 CALIFORNIA CHILDREN'S HOSPITAL ASSOCIATION 624b8b69-db03-49e4-af38-85665801ec19 Q3 CALIFORNIA CHILDREN'S HOSPITAL ASSOCIATION 401104267 CALIFORNIA CHILDREN'S HOSPITAL ASSOCIATION 2019 third_quarter MMM Supporting funding in FY 2020 budget for Children's Hospital Graduate Medical Education program. Supporting effort to delay/eliminate cuts to Disproportionate Share Hospitals. Commented on proposed changes to the Medicare Hospital Outpatient Prospective Payment rule and the Medicare Physician Fee Schedule rule. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   15000 0 0 2019-10-11T19:23:27.973000-04:00
2340905 BLUE MOUNTAIN STRATEGIES 01270791-013e-405c-8bc0-4454a92001dd Q3 BLUE MOUNTAIN STRATEGIES 401104249 SIXTEENTHIRTY FUND 2019 third_quarter MMM Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383, Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019. SENATE 40000   0 0 2019-10-12T10:38:52.560000-04:00
2340932 RED+BLUE STRATEGIES ea8b8966-d6eb-4f59-831a-84b53fdf86fc Q3 RED+BLUE STRATEGIES 400693064 CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS 2019 third_quarter MMM Executive actions impacting children's health care including potential regulations designed to restructure the Medicaid program. Implementation issues regarding the ACE Kids Act. H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 - Support of the the title including policies focused on improving supports for children with multiple chronic conditions and other critical provisions. Issues related to helping military families access the health care coverage and treatment for which they are eligible. Issues related to the treatment of the treatment of Disproportionate Care Hospitals under the Medicaid program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2019-10-13T08:49:20.590000-04:00
2340935 RED+BLUE STRATEGIES 342d36e3-73ba-4521-b954-8b883435e4d5 Q3 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2019 third_quarter MMM H.R. 3 - The Lower Drug Costs Now Act of 2019 - Issues related to the role of PBMs in the new structure contemplated by the Act. HHS rules and regulations related to the cost of prescription drugs, including, but not limited to, limiting rebates in the Medicare and Medicaid prescription drug benefits. Legislative policies and reforms related to Medicare Part B and D specific to the price of prescription medications. C-THRU Act (S. 476) - Issues related to transparency in the PBM space and ensuring that tools to decrease the cost of prescription medications are maintained. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-10-13T09:10:22.420000-04:00
2340940 RED+BLUE STRATEGIES 40b518c7-428a-4ef2-a260-3966f9bc943c Q3 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2019 third_quarter MMM H.R. 2482 - The Mainstreaming Addiction Treatment Act of 2019 - Support for policies increasing the ability to access MAT to treat addiction. Regulations promulgated by ONC and HHS related to patient matching, interoperability, unique patient identifiers, unique device identifiers and other HIT tools that can support better patient safety in the Medicare and Medicaid systems. Issues related to the implementation on the SUPPORT Act (P.L. 115-271) as they relate to curbing opioid abuse and substance use disorder for Medicare beneficiaries. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2019-10-13T09:20:24.133000-04:00
2340942 RED+BLUE STRATEGIES 276fde68-1270-4d3c-aca8-1df5c8cb2d5a Q3 RED+BLUE STRATEGIES 400693064 COMMUNITY CATALYST 2019 third_quarter MMM H.R. 3 - The Lower Drug Costs Act Now Act of 2019 - Issues related to ensuring that prescription medications are affordable to consumers. H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 - Issues related to protecting programs regarding spousal impoverishment, money follows the person and ACE Kids. The Beneficiary Education Tools, Telehealth, and Extender Reauthorization Act of 2019 (the Better Act) - issues related to quality and beneficiary enrollment. H.R. 3253 - Empowering Beneficiaries, Ensuring Access and Strengthening Accountability Act of 2019 - Reauthorizing money follows the person and spousal impoverishment programs in the Medicaid program. Issues related to programs supporting the health of individuals dually eligible for Medicare anf Medicaid. Administration guidance and rules regarding Medicaid expansion and work requirements. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2019-10-13T09:25:24.997000-04:00
2340944 RED+BLUE STRATEGIES 3eaa0512-8d85-499c-be70-c0e8700dbc37 Q3 RED+BLUE STRATEGIES 400693064 DAVITA INC. 2019 third_quarter MMM Administrative actions and demonstrations related coverning care for people with chronic kidney disease and End Stage Renal Disease (ESRD). Legislative policies related to ensuring that people living with End Stage Renal Disease (ESRD) who are covered through Medicare Fee for Service (FFS) have the supports and services they need. HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2019-10-13T09:31:25.890000-04:00
2340990 RED+BLUE STRATEGIES 17ed0b2e-1506-4a55-999d-45b99acb5233 Q3 RED+BLUE STRATEGIES 400693064 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS 2019 third_quarter MMM H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries. HHS proposed rules related the treatment of rebates in Medicare Part D. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-10-13T20:26:51.417000-04:00
2340994 RED+BLUE STRATEGIES ef2e07b4-dee8-4a4a-a71a-aefb1e39d4b1 Q3 RED+BLUE STRATEGIES 400693064 AMERICAN SOCIETY FROM RADIATION ONCOLOGY (ASTRO) 2019 third_quarter MMM H.R. 3107 - Issues related to practices regarding prior authorization for certain cancer treatments. Issues related to CMMI's treatment of proposals for the Radiation Oncology Advance Payment Model (ROAPM) Issues related to ensuring that cancer patients in rural and underserved communities have access to radiation oncology services if it is part of their treatment plans. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-10-13T20:37:53.943000-04:00
2340996 RED+BLUE STRATEGIES e6cab4c8-7a1a-4c3e-9d8a-effed312664e Q3 RED+BLUE STRATEGIES 400693064 BOSTON MEDICAL CENTER 2019 third_quarter MMM H.R. 3 - Lower Drug Costs Now Act - Issues related to the 340(b) program and keeping drugs affordable for lower income Americans. S. 1895 - Lower Health Care Costs Act - Issues related to surprise billing and transparency. Issues related to expanding the GME program to allow for additional slots to train physicians in the fight against addiction. Policies related to social determinants of health (SDH) with a focus on food as medicine, the importance of stable housing and the need for caregiving supports to help patients to get well and stay well. Support for the reauthorization of a strong, stable Medicaid DSH program. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-10-13T20:41:54.710000-04:00
2340997 RED+BLUE STRATEGIES 28eb5500-73f0-49d3-9086-e13039b6da80 Q3 RED+BLUE STRATEGIES 400693064 THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA 2019 third_quarter MMM H.R. 3 - Lower Drug Costs Now Act - Issues related to the potential creating of a comprehensive Medicare dental benefit. Issues related to ensuring quality eye and oral health in the Medicaid program. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-10-13T20:49:55.530000-04:00
2341000 RED+BLUE STRATEGIES d37fd4fe-62ce-4912-8760-5109003d94eb Q3 RED+BLUE STRATEGIES 400693064 QUEST DIAGNOSTICS INCORPORATED 2019 third_quarter MMM H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2019-10-13T20:55:56.350000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2230.841ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API